跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
BRIVARACETAM VISO FARMACEUTICA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Approved
STANDARD
BRIVARACETAM VISO FARMACEUTICA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 29, 2025
Approval ID
846c1f18a7066e64
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
846c1f18a7066e64
Drug Cima Aemps Name
BRIVARACETAM VISO FARMACEUTICA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Register Number
90363
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Viso Farmaceutica S.L.U.
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2025-05-29
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
BRIVARACETAM
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 29, 2025
Approval ID
846c1f18a7066e64
Type
Standard
Back to CIMA-AEMPS Approvals
BRIVARACETAM VISO FARMACEUTICA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG - CIMA-AEMPS Drug Approval Details
